← all works
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet
- Topic
- Viral Infections and Outbreaks Research
- Field
- Medicine
- Canadian institutions
- —
- Funders
- Health CanadaNorges ForskningsrådU.S. Department of DefenseEuropean CommissionWorld Health OrganizationDepartment for International Development, UK GovernmentPublic Health Agency of CanadaWellcome TrustCanadian Institutes of Health ResearchMédecins Sans FrontièresWellcomeUtenriksdepartementetBill and Melinda Gates FoundationInternational Development Research Centre
- Keywords
- Ebola vaccineEbola virusMedicineVaccinationVirologyImmunologyVirus
- Has abstract in OpenAlex
- no